Aripiprazole Treatment of Bipolar Depression
Sponsored by Indiana University School of Medicine
About this trial
Last updated 18 years ago
Study ID
69883
Status
Completed
Type
Interventional
Phase
Phase 4
Placebo
No
Accepting
18 to 65 Years
All
Not accepting
Healthy Volunteers
Trial Timing
Ended 19 years ago
What is this trial about?
This is a study of addition of aripirazole to the treatment of bipolar depressed patients who
are not better on the medications that they are currently receiving.
What are the participation requirements?
Inclusion Criteria
- 1) Male or female between 18 - 65 years of age, inclusive 2) Satisfy DSM-IV criteria for bipolar disorder depressed phase i.e.,duration of depression > 2 weeks) 3) No change in psychotropic medication or their doses within 2 weeks of inclusion in The study. 4) Inadequately responsive to or intolerant of prior pharmacotherapy as determined by the investigator 5) 17-item Hamilton Depression Rating Scale Score > 15 6) Young Mania Rating Scale (Young, et. al., 1978) (YMRS) < 10.